• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

23.67 -0.37 (-1.54%)
Official Closing Price Updated: 7:00 PM EDT, Jun 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 57,957,630
Open 24.19
Bid (Size) 23.72 (300)
Ask (Size) 23.73 (200)
Prev. Close 24.04
Today's Range 23.62 - 24.34
52wk Range 23.11 - 28.75
Shares Outstanding 5,606,688,356
Dividend Yield 7.27%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026? ↗
Today 17:15 EDT
AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics. 
Via The Motley Fool
Topics Intellectual Property
News headline image
An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right? ↗
Today 11:38 EDT
Novo Nordisk is no longer the front-runner, but it's not out of the running, either. 
Via The Motley Fool

Performance

YTD
-6.0%
-6.0%
1 Month
-8.4%
-8.4%
3 Month
-14.1%
-14.1%
6 Month
-5.7%
-5.7%
1 Year
-2.4%
-2.4%

More News

Read More
News headline image
FDA Expands Pfizer's Ibrance Label For Frontline Maintenance In Advanced Breast Cancer ↗
Today 9:35 EDT
Via Benzinga
Most active S&P500 stocks in Wednesday's session ↗
June 24, 2026
Via Chartmill
News headline image
2 Large-Cap Stocks to Target This Week and 1 We Find Risky
Today 0:33 EDT
Via StockStory
News headline image
Pfizer Declares Third-Quarter 2026 Dividend
June 24, 2026
From Pfizer Inc.
Via Business Wire
News headline image
The Highest Dividend Yields Are Often the Least Safe. Here's How to Tell the Difference. ↗
June 24, 2026
Via Talk Markets
News headline image
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
June 24, 2026
From Pfizer Inc.
Via Business Wire
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026
Via Investor Brand Network
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
June 24, 2026
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Pfizer Stock Trades Flat Following Mixed Phase 3 Lung Cancer Trial Data ↗
June 24, 2026
Via Benzinga
News headline image
2 High-Yield Dividend Stocks to Buy and Hold for a Decade ↗
June 23, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026
From BioMedWire
Via GlobeNewswire
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗
June 23, 2026
Via Chartmill
News headline image
Pfizer's Lung Cancer Drug Candidate Falls Short Overall, Shows Benefit In Select Patients ↗
June 23, 2026
Via Benzinga
News headline image
Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts
June 23, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
June 22, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Stock Edges Lower Monday: What's Going On? ↗
June 22, 2026
Via Benzinga
News headline image
GEA Group Aktiengesellschaft Targets EUR 7B Revenue, Higher Margins by 2030 ↗
June 22, 2026
Via MarketBeat
Topics Supply Chain
News headline image
Pfizer Isn't Expecting to Make Any Big Acquisition in the Next Couple of Years, but It's Planning to Do This Instead ↗
June 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Earnings Intellectual Property
News headline image
GLP-1 Receptor Agonist Market Revenue Analysis Across Key Regions ↗
June 22, 2026
Via Talk Markets
News headline image
2 Reasons to Like ZTS and 1 to Stay Skeptical
June 22, 2026
Via StockStory
News headline image
Could Pfizer Stock Be Your Ticket to Generational Wealth? ↗
June 21, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Want to Retire on $500,000? 3 Stocks to Buy and Never Sell ↗
June 21, 2026
Via The Motley Fool
Topics Artificial Intelligence Retirement
News headline image
Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors? ↗
June 20, 2026
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 23.67
When was Pfizer last traded?
The last trade of Pfizer was at 06/25/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 132.71B
How many shares of Pfizer are outstanding?
Pfizer has 133B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap